TABLE 1.
N (%) | |
---|---|
Number of patients | 31 |
Median age, years (range)* | 61.1 (32.8-84.9) |
Sex | |
Male | 18 (58.1) |
Female | 13 (41.9) |
Primary cancer | |
Squamous cell carcinoma | 7 (22.6) |
Esthesioneuroblastoma | 5 (16.1) |
Astrocytoma | 2 (6.5) |
Atypical meningioma | 2 (6.5) |
Basal cell carcinoma | 2 (6.5) |
Meningioma | 2 (6.5) |
Lymphoma | 1 (3.2) |
Chondrosarcoma | 1 (3.2) |
Ewing sarcoma | 1 (3.2) |
Fibroxanthoma | 1 (3.2) |
Hemangiopericytoma | 1 (3.2) |
Melanoma | 1 (3.2) |
Oligoastrocyroma | 1 (3.2) |
Oligodendroglioma | 1 (3.2) |
Osteosarcoma | 1 (3.2) |
Pleomorphic adenoma | 1 (3.2) |
Seminoma | 1 (3.2) |
Treatments for primary cancer | |
Adjuvant chemotherapy | 18 (58.1) |
Surgery | 31 (100) |
Adjuvant radiation | 31 (100) |
Median radiation dose, Gy (range) | 60 (30-70) |
Radiation type | |
IMRT | 9 (29.03) |
SRS | 2 (6.5) |
Proton beam | 2 (6.5) |
Electron beam | 1 (3.2) |
Unknown | 17 (54.8) |
IMRT, intensity-modulated radiation therapy; SRS, stereotactic radiosurgery.